Industry · NAICS 325413

In-Vitro Diagnostic Substance Manufacturing

Open notices · Coming up for re-bid · Who wins this work · Typical award sizes

Money by year

  • FY2023$1.95B
  • FY2024$149.16M
  • FY2025$170.54M
  • FY2026$176.54M

Obligations (money committed) in prime awards, from USAspending.gov.

Companies winning it, FY2025

  1. Danaher Corp $38.67M
  2. Biomerieux Inc $30.37M
  3. Roche Holding Ag $18.90M
  4. Abbott Laboratories $7.05M
  5. Thermo Fisher Scientific Inc. $5.46M
  6. Hologic Sales and Service, LLC $4.96M
  7. Quidelortho Corp $4.42M
  8. Siemens $4.15M
  9. Abbott Molecular Inc. $2.96M
  10. Immucor Inc $2.95M

Where the work is, FY2025

  1. California $41.13M
  2. Utah $25.59M
  3. Indiana $12.91M
  4. Illinois $11.63M
  5. Massachusetts $8.61M
  6. Texas $8.36M
  7. Maryland $7.32M
  8. Georgia $6.63M

Contracts ending in the next 12 months

48 contracts, $158.33M with options. The largest:

ContractIncumbentEndsValue with options
36C24126N0005
MICROBIOLOGY REAGENTS & CONSUMABLES ADD CLAUSE 852.222-71 - COMPLIANCE WITH EXECUTIVE ORDER 13899
Cepheid2026-10-19$2.35M
75A50424C00006
OVER THE COUNTER (OTC) COVID-19 TESTS - GAO CORRECTIVE ACTION
Atlantic Trading LLC2026-10-29$26.51M
W91YTZ25C0003
SLR FY25 CHEMISTRY ANALYZER/TESTING MACH
Abbott Laboratories Inc.2026-10-31$3.48M
36C26026F0090
REAGENTS AND CONSUMABLES FOR LABORATORY TESTS.
Abbott Molecular Inc.2026-11-30$5.00M
36C26024P0112
BIOFIRE REAGENT (KITS
Biofire Diagnostics LLC2026-11-30$1.06M
36C25726N0164
CEPHEID REAGENTS CONTRACT - ORDERING PERIOD 1
Cepheid2026-12-21$1.56M
36C25722P0194
ACCESS BNP REAGENTS
Beckman Coulter, Inc2026-12-31$2.09M
36C24826N0280
MOLECULAR PATHOGEN DETECTION
Biomerieux Inc2027-01-12$2.47M
36C24826N0110
MOLECULAR PATHOGEN DETECTION
Biomerieux Inc2027-01-12$1.14M
36C25626N0333
REAGENTS BIOFIRE ANALYZER MEDVAMC
Biomerieux Inc2027-01-19$4.29M

All of them, with filters →

Open notices

All 9 open notices →

From USAspending.gov prime awards and SAM.gov notices. Sources and limits